+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Drug-Device Combination Products Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5715527
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug-Device Combination Products Market is experiencing significant transformation, driven by evolving clinical expectations, regulatory dynamics, and rapid technological innovation. This report delivers a focused, actionable analysis designed for senior leaders seeking to understand the complexities and growth opportunities presented by combination therapeutics.

Market Snapshot

In 2025, the Drug-Device Combination Products Market was valued at USD 156.46 billion, growing to USD 168.70 billion in 2026. With a projected CAGR of 8.36%, market size is forecast to reach USD 274.61 billion by 2032. This growth is powered by the convergence of pharmaceutical innovations and device engineering, alongside expanding use cases across various therapeutic areas and healthcare channels.

Scope & Segmentation

  • Product Types: Includes drug-eluting stents, inhalers, injector systems, prefilled syringes and pens, topical medicines, and transdermal patches. Injector systems are further segmented into auto-injectors and needle-free injectors, each with unique device engineering considerations.
  • Technologies: Covers advanced release technologies, biodegradable solutions, conventional device-drug technology, and smart device technologies. Smart device offerings emphasize features such as automatic dosing and digital monitoring, creating diverse regulatory and data integration challenges.
  • Dosage Forms: Encompasses liquid, semi-solid, and solid dosage forms. Semi-solid formats break down into creams, ointments, and powders, while solid dosage forms include capsules and tablets, each presenting specific compatibility and stability demands.
  • Therapeutic Classes: Targets cardiovascular, diabetes and endocrinology, hormonal therapy, oncology, and pain management applications. Oncology products diversify between traditional chemotherapy and participatory treatments focused on real-world patient monitoring.
  • End-User Channels: Segmentation extends across ambulatory surgical centers, homecare, hospitals and clinics, as well as specialty clinics; each setting shapes custom requirements for training, packaging, and support.
  • Geographies Covered: The report provides in-depth insights for the Americas, Europe, Middle East & Africa, and Asia-Pacific, outlining how local governance, reimbursement models, and manufacturing hubs influence development and adoption strategies.

Drug-Device Combination Products Market: Key Takeaways

  • Cross-functional teams now drive combination product innovation, blending pharmacological development, device engineering, and regulatory strategy to accelerate clinical progress and market entry.
  • Smart technologies and digital monitoring are advancing human factors integration, improving therapeutic outcomes by enabling real-time patient engagement and adherence tracking.
  • Manufacturers are investing in modular production platforms and specialized capabilities to support iterative prototyping and ensure rapid, compliant scale-up in response to shifting clinical and commercial demands.
  • Partnerships—across device specialists, pharma, and digital innovators—are increasingly used to bridge talent and capability gaps, giving firms agility in development and delivery.
  • Regional variations in regulatory frameworks and payer environments drive the need for localized evidence generation and strategic adaptation, affecting timelines and commercialization approaches.
  • Effective intellectual property management and data-driven decision making are pivotal to building and sustaining competitive advantage across the product lifecycle.

Tariff Impact

The 2025 U.S. tariff regime has significantly shaped sourcing and procurement strategies for combination product manufacturers. Localizing supply chains for high-dependency components, nearshoring suppliers, and managing tariff-driven cost volatility have become central to ensuring resilience and operational continuity. Procurement and quality teams are refining supplier qualification processes to maintain compliance standards amid shifts in sourcing, while executive leaders reassess vertical integration and pricing strategies to protect margins.

Methodology & Data Sources

This report integrates expert interviews with cross-disciplinary executives, regulatory review, and patent analysis. Findings have been benchmarked across geographies and validated with industry specialists. The approach emphasizes source transparency, data consistency, and explicit documentation of analytic assumptions.

Why This Report Matters

  • Provides strategic, evidence-based guidance for aligning governance and investment in the Drug-Device Combination Products Market.
  • Offers actionable segmentation and regional insights to inform pipeline development, sourcing, and commercialization priorities.
  • Enables informed decision-making by distilling complex regulatory, technological, and market dynamics into practical recommendations.

Conclusion

Integrated technical, regulatory, and commercial strategies are essential for capitalizing on growth in combination therapeutics. This report empowers decision-makers to balance innovation with operational discipline, leveraging collaboration and digital insights for sustained success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Drug-Device Combination Products Market, by Product Type
8.1. Drug-Eluting Stents
8.2. Inhalers
8.3. Injector Systems
8.3.1. Auto-Injectors
8.3.2. Needle-Free Injectors
8.4. Prefilled Syringes & Pens
8.5. Topical Medicines
8.6. Transdermal Patches
9. Drug-Device Combination Products Market, by Technology
9.1. Advanced Release Technologies
9.2. Biodegradable Technology
9.3. Conventional Device-Drug Technology
9.4. Smart Device Technologies
9.4.1. Automatic Dosing
9.4.2. Digital Monitoring
10. Drug-Device Combination Products Market, by Dosage Form
10.1. Liquid Dosage Forms
10.2. Semi-Solid Dosage Forms
10.2.1. Creams
10.2.2. Ointments
10.2.3. Powders
10.3. Solid Dosage Forms
10.3.1. Capsules
10.3.2. Tablets
11. Drug-Device Combination Products Market, by Therapeutic Class
11.1. Cardiovascular Medications
11.2. Diabetes & Endocrinology
11.3. Hormonal Replacement Therapy
11.4. Oncology Drugs
11.4.1. Chemotherapy
11.4.2. Participatory Oncology Treatment
11.5. Pain Management
12. Drug-Device Combination Products Market, by End-User
12.1. Ambulatory Surgical Centers
12.2. Homecare Settings
12.3. Hospitals and Clinics
12.4. Specialty Clinics
13. Drug-Device Combination Products Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Drug-Device Combination Products Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Drug-Device Combination Products Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Drug-Device Combination Products Market
17. China Drug-Device Combination Products Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. AbbVie Inc.
18.7. B. Braun SE
18.8. Baxter International Inc.
18.9. Becton, Dickinson and Company
18.10. BIOTRONIK SE & Co. KG
18.11. Boston Scientific Corporation
18.12. Braile Biomédica
18.13. Cardinal Health, Inc.
18.14. CODAN Companies
18.15. Cook Group Incorporated
18.16. F. Hoffmann-La Roche Ltd.
18.17. Fresenius Kabi
18.18. ICU Medical, Inc.
18.19. InSitu Technologies Inc.
18.20. JMS North America Corporation
18.21. Lepu Medical Technology Company
18.22. Medtronic PLC
18.23. MicroPort Scientific Corporation
18.24. Novartis AG
18.25. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
18.26. SOOIL Developments Co., Ltd.
18.27. Stryker Corporation
18.28. Teleflex Incorporated
18.29. Terumo Group
18.30. Viatris Inc.
18.31. W. L. Gore & Associates Inc.
List of Figures
FIGURE 1. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES & PENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES & PENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES & PENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TOPICAL MEDICINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TOPICAL MEDICINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TOPICAL MEDICINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ADVANCED RELEASE TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ADVANCED RELEASE TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ADVANCED RELEASE TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY BIODEGRADABLE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY BIODEGRADABLE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY BIODEGRADABLE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CONVENTIONAL DEVICE-DRUG TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CONVENTIONAL DEVICE-DRUG TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CONVENTIONAL DEVICE-DRUG TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTOMATIC DOSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTOMATIC DOSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AUTOMATIC DOSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIGITAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIGITAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIGITAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY LIQUID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY LIQUID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR MEDICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR MEDICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR MEDICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES & ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES & ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES & ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HORMONAL REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HORMONAL REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HORMONAL REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PARTICIPATORY ONCOLOGY TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PARTICIPATORY ONCOLOGY TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PARTICIPATORY ONCOLOGY TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 161. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 162. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 166. EUROPE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 178. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 183. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 184. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 185. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 186. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 187. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 188. AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 204. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 206. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 207. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 208. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 209. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 210. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 211. ASEAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 212. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 215. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 217. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 218. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 219. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 220. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 221. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 222. GCC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 234. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 237. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 238. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 239. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 240. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 241. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 242. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 243. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 244. BRICS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 245. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 248. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 250. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 251. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 252. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 253. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 254. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 255. G7 DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 256. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 259. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 260. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 261. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 262. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 263. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 264. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 265. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 266. NATO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ONCOLOGY DRUGS, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 279. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 281. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INJECTOR SYSTEMS, 2018-2032 (USD MILLION)
TABLE 282. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 283. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SMART DEVICE TECHNOLOGIES, 2018-2032 (USD MILLION)
TABLE 284. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 285. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SEMI-SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 286. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2032 (USD MILLION)
TABLE 287. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY THERAPEUTIC C

Companies Mentioned

The key companies profiled in this Drug-Device Combination Products market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomédica
  • Cardinal Health, Inc.
  • CODAN Companies
  • Cook Group Incorporated
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi
  • ICU Medical, Inc.
  • InSitu Technologies Inc.
  • JMS North America Corporation
  • Lepu Medical Technology Company
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Novartis AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • SOOIL Developments Co., Ltd.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Group
  • Viatris Inc.
  • W. L. Gore & Associates Inc.

Table Information